Search For "intranasal"
AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Fr
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
Read More
COVID-19: Nasal vaccine could be a game-changer if it provides mucosal imm
Updated : 4 years, 1 month ago IST
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Read More
Study develops intranasal flu vaccine with nano-particles that provides ro
Updated : 4 years, 1 month ago IST
Washington [US], January 30 (ANI): A new study has developed an influenza vaccine that is administered through the nose and has been constructed with nanoparticles that increase the immune response and offers stronger protection.
Read More
Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials
Updated : 4 years, 1 month ago IST
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 2 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Nasal vaccine might help fight new COVID-19 variants: Study
Updated : 4 years, 3 months ago IST
Connecticut [US], December 11 (ANI): In a new study by Yale's Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology, it was found that intranasal vaccination provided broad-based protection against heterologous respiratory viruses in mice.
Read More
AIIMS Delhi to conduct Phase 2/3 clinical trials of Bharat Biotech's nasal
Updated : 4 years, 6 months ago IST
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday.
Read More
Inhaled COVID-19 vaccine prevents disease, virus transmission in animals:
Updated : 4 years, 8 months ago IST
Washington [US], July 9 (ANI): In a new study assessing the potential of a single-dose, intranasal COVID-19 vaccine, a team from the University of Iowa and the University of Georgia found that the vaccine fully protects mice against lethal COVID-19 infection. The vaccine also blocks the anim
Read More
Bharat Biotech inks licensing deal with WUSM to advance COVID-19 intranasa
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], September 24 (ANI): Vaccine Innovator, Bharat Biotech on Wednesday announced, a licensing agreement with Washington University School of Medicine (WUSM) in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for COVID-19.
Read More
Bharat Biotech developing 'CoroFlu' intranasal vaccine for Coronavirus
Updated : 5 years, 11 months ago IST
Hyderabad (Telangana) [India], Apr 4 (ANI): Bharat biotech is developing a one drop COVID-19 intranasal vaccine 'CoroFlu' using a proven safety platform.
Read More